Letter: Job Search Sources

"Science Societies: A Source Of Leads For The Job Hunter" The Scientist, Dec. 11, 1989, page 20) includes an observation containing a quotation, both presenting an incorrect impression about the Placement Services of the Federation of American Societies for Experimental Biology (FASEB) and the Society for Neuroscience (SN). I refer to this: ". . . they're `not very useful for people who want to work for large companies, like Abbott Labs, Merck, and Du Pont . . .' because few turn to science-so

Written byThomas L. Trudeau
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

"Science Societies: A Source Of Leads For The Job Hunter" The Scientist, Dec. 11, 1989, page 20) includes an observation containing a quotation, both presenting an incorrect impression about the Placement Services of the Federation of American

Societies for Experimental Biology (FASEB) and the Society for Neuroscience (SN). I refer to this: ". . . they're `not very useful for people who want to work for large companies, like Abbott Labs, Merck, and Du Pont . . .' because few turn to science-society services as a source of candidates." Actually, those three companies sent an aggregate of 58 individuals to interview candidates during Placement Service operations at the 1988 and 1989 annual meetings of FASEB and SN. Just at the 1989 FASEB annual meeting, those three and 18 similar companies participated, sending 50 interviewers. The direct-dial telephone number for FASEB and SN Placement Services is (301) 530-7020.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies